Analyst Ranking
Bottom 5%
#4885 out of 5100 analysts
Average Return
-5.63%
Win Rate
40%36 out of 89
Risk vs Reward
Poor
Good

Eric Joseph's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Revolution Medicines IncRVMD
+176.50%$21.49$59.42
2023-11-07 -
2024-11-06
Strong Buy
Tg Therapeutics IncTGTX
+173.91%$13.99$38.32
2024-04-18 -
2025-04-17
Strong Buy
Tg Therapeutics IncTGTX
+147.63%$10.12$25.06
2023-11-01 -
2024-10-31
Strong Buy
Tg Therapeutics IncTGTX
+103.76%$10.10$20.58
2023-08-07 -
2024-08-06
Strong Buy
Kymera Therapeutics IncKYMR
+101.87%$32.17$64.94
2025-05-12 -
2025-11-14
Strong Buy

Eric Joseph Analyst Color

Get additional color on Eric Joseph's coverage of popular stocks

Eric Joseph's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Tg Therapeutics IncTGTX
5Strong Buy$49.00+58.06%Maintains
13 days ago
Beam Therapeutics IncBEAM
4Strong Buy$46.00+111.79%Maintains
a month ago
Kymera Therapeutics IncKYMR
4Strong Buy$64.00-1.45%Maintains
5 months ago
Rocket Pharmaceuticals IncRCKT
3Strong Buy$44.00+1,342.62%Maintains
6 months ago
Novavax IncNVAX
8Strong Sell$7.00+0.43%Maintains
6 months ago
Ptc Therapeutics IncPTCT
10Strong Buy$67.00-11.02%Maintains
6 months ago
Nurix Therapeutics IncNRIX
7Strong Buy$30.00+134.38%Maintains
10 months ago
Vir Biotechnology IncVIR
5Hold$14.00+148.67%Maintains
10 months ago
Revolution Medicines IncRVMD
6Strong Buy$71.00+4.80%Maintains
a year ago
Septerna IncSEPN
1Strong Buy$38.00+63.34%Initiates Coverage On
a year ago
Camp4 Therapeutics CorpCAMP
1Strong Buy$23.00N/AInitiates Coverage On
a year ago
Wave Life Sciences LtdWVE
2Strong Buy$17.00N/AMaintains
a year ago
Igm Biosciences IncIGMS
7Strong Sell$9.00N/ADowngrades
a year ago
Relay Therapeutics IncRLAY
5Strong Buy$21.00N/AMaintains
a year ago
Enanta Pharmaceuticals IncENTA
4Strong Sell$10.00N/AMaintains
a year ago
Hillevax IncHLVX
3Strong Buy$24.00N/AMaintains
2 years ago
Prime Medicine IncPRME
4Strong Buy$15.00N/AMaintains
2 years ago
C4 Therapeutics IncCCCC
4Hold$6.00N/AUpgrades
2 years ago
Livent CorpLTHM
2Hold$15.00N/AMaintains
2 years ago
Recursion Pharmaceuticals IncRXRX
2Hold$10.00N/AMaintains
2 years ago
Monte Rosa Therapeutics IncGLUE
2Strong Buy$11.00N/AMaintains
2 years ago
Akero Therapeutics IncAKRO
2Strong Buy$41.00N/AMaintains
2 years ago
Lyell Immunopharma IncLYEL
1Hold$100.00N/ADowngrades
2 years ago
Century Therapeutics IncIPSC
2Hold$5.00N/ADowngrades
2 years ago
Pliant Therapeutics IncPLRX
3Strong Buy$48.00N/AMaintains
2 years ago
Terns Pharmaceuticals IncTERN
6Hold$11.00N/AMaintains
2 years ago
Bluebird Bio IncBLUE
1Strong Buy$140.00N/AInitiates Coverage On
3 years ago
Atea Pharmaceuticals IncAVIR
4Hold$8.00N/AMaintains
3 years ago
Mirati Therapeutics IncMRTX
1Hold$65.00N/ADowngrades
3 years ago
Surrozen IncSRZN
2Strong SellN/AN/ADowngrades
3 years ago
Karyopharm Therapeutics IncKPTI
2Hold$120.00N/AUpgrades
4 years ago
Aligos Therapeutics IncALGS
2Hold$300.00N/ADowngrades
4 years ago
Omeros CorpOMER
2Strong SellN/AN/ADowngrades
4 years ago
Freeline Therapeutics Holdings PLCFRLN
2Hold$120.00N/ADowngrades
4 years ago
Verve Therapeutics IncVERV
1Hold$50.00N/AInitiates Coverage On
4 years ago
Achilles Therapeutics PLCACHL
1Strong Sell$11.00N/AInitiates Coverage On
5 years ago
Acceleron Pharma IncXLRN
1Strong Buy$153.00N/AMaintains
5 years ago
Autolus Therapeutics PLCAUTL
2Hold$9.00N/ADowngrades
5 years ago
Akebia Therapeutics IncAKBA
1Strong SellN/AN/ADowngrades
5 years ago
Urovant Sciences LtdUROV
2Hold$16.00N/ADowngrades
5 years ago
Five Prime Therapeutics IncFPRX
2Hold$14.00N/AUpgrades
5 years ago
Obseva SaOBSVF
1Hold$5.00N/ADowngrades
5 years ago
Black Diamond Therapeutics IncBDTX
1Strong Buy$42.00N/AInitiates Coverage On
6 years ago
Momenta Pharmaceuticals IncMNTA
1Strong Buy$30.00N/AUpgrades
6 years ago
Ironwood Pharmaceuticals IncIRWD
2Hold$13.00N/AUpgrades
7 years ago
Sangamo Therapeutics IncSGMO
2Hold$11.00N/AMaintains
7 years ago
Opko Health IncOPK
2Strong SellN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.